相关实验视频
Updated: Jan 17, 2026

06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.4K
下一代T细胞免疫疗法使用CRISPR基和主要编辑进行工程设计:挑战和机遇
Karl Petri1,2,3, Elvira D'Ippolito4,5, Annette Künkele6,7
1Chair of Cellular Immunotherapy, Medical Clinic and Policlinic II, University Hospital Würzburg, Würzburg, Germany. petri_k@ukw.de.
Nature reviews. Clinical oncology
|September 19, 2025
概括
新的CRISPR 2.0技术精确地设计T细胞用于癌症免疫治疗. 这些先进的基础和主要编辑工具克服了早期CRISPR系统的局限性,提高了血液癌症和固体瘤的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 采用T细胞疗法对血液癌症有前途,但面临诸如耐药性和固体瘤的有效性有限等挑战.
- 传统的CRISPR-Cas9基因编辑可以导致意外的遗传改变,使治疗应用复杂化.
研究的目的:
- 审查CRISPR 2.0技术的进展,包括基础和主要编辑,以增强细胞免疫疗法.
- 讨论CRISPR 2.0在克服基于T细胞的癌症治疗当前局限性的潜力.
主要方法:
- 审查新兴的CRISPR 2.0技术 (基础编辑和主要编辑).
- 分析它们在用于免疫治疗的精密工程初级T细胞中的应用.
- 检查临床转化方面的进展情况.
主要成果:
- 克里斯普 2.0 能够在T细胞中进行精确的核酸修饰,从而对基因编辑提供了更好的控制.
- 这些技术可以增强免疫细胞功能,扩大向抗原,并简化治疗生产.
- 克里斯普尔2.0正在向临床应用迈进,正在进行改造细胞疗法的试验.
结论:
- 克里斯普尔2.0代表了细胞免疫疗法的重大进步,提供了更高的精度和多功能性.
- 这些工具有望改善T细胞疗法,对抗血液性恶性瘤和固体瘤.
- 对CRISPR 2.0的进一步开发和临床转化对于实现其在癌症治疗中的全部潜力至关重要.
相关概念视频
CRISPR
57.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K
CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
What is Genetic Engineering?
79.6K
Overview
79.6K
Homologous Recombination
62.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.7K
Conservative Site-specific Recombination and Phase Variation
6.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.7K

